Shock trial registry

SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry.

SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK? Am Heart J. Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry.

Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry.

Am J Med. Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry.

One-year survival following early revascularization for cardiogenic shock. Eur Heart J. Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. Menon V, Fincke R. Congest Heart Fail. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock.

Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial.

Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on month survival in the SHOCK trial. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. Electrocardiographic findings in cardiogenic shock, risk prediction, and the effects of emergency revascularization: results from the SHOCK trial. Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction.

Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock SHOCK trial.

Racial and ethnic differences in the treatment and outcome of cardiogenic shock following acute myocardial infarction. Am J Cardiol.

Epub Aug Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. National Library of Medicine U. National Institutes of Health U. Department of Health and Human Services.

Procedure: angioplasty, transluminal, percutaneous coronary Procedure: coronary artery bypass Drug: thrombolytic therapy. Phase 3. Study Type :. Interventional Clinical Trial. Study Start Date :. Actual Primary Completion Date :. Actual Study Completion Date :. October 28, Key Record Dates. Results: Left ventricular failure was the most frequent cause of CS for both gender groups. Women in the SHOCK Registry had a significantly higher incidence of mechanical complications including ventricular septal rupture and acute severe mitral regurgitation.

Among patients with predominant LV failure, women were, on average, 4. Conclusions: Women with CS complicating AMI had more frequent adverse clinical characteristics and mechanical complications.

Women derived the same benefit as men from revascularization, and gender was not independently associated with in-hospital mortality in the SHOCK Registry. Abstract Objectives: The aim of this study was to assess the impact of gender on clinical course and in-hospital mortality in patients with cardiogenic shock CS complicating acute myocardial infarction AMI.